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Edited by Masayuki MiyasakaAbstract We previously reported that inactivated Sendai virus
particle (hemagglutinating virus of Japan envelope; HVJ-E)
has anti-tumor eﬀects by eliciting IL-6 production in dendritic
cells (DCs). In the present study, we investigated which compo-
nents of HVJ-E elicit IL-6 production. HVJ-E containing F0
protein inactive for virus envelope–cell membrane fusion en-
hanced IL-6 production. Reconstituted liposomes containing F
protein stimulated IL-6 production. The antibody against F pro-
tein inhibited IL-6 secretion by HVJ-E. When carbohydrate
chains of the F glycoprotein were removed, HVJ-E lost the abil-
ity to stimulate IL-6 secretion. These results suggest that F gly-
coprotein is required for IL-6 production in DCs.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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IL-61. Introduction
Sendai virus (hemagglutinating virus of Japan; HVJ), a
paramyxovirus strain, is known as a robust inducer of host im-
mune response. The virus is able to induce the maturation of
dendritic cells (DCs) by a toll-like receptor (TLR) independent
pathway, and produce various cytokines including type I inter-
feron (IFN) from DCs [1–3]. Recently, the IFN production by
HVJ is elucidated to be mediated by recognition of viral
dsRNA by RIG-I [4]. On the other hand, HVJ is also famous
for cell fusion activity [5]. Two distinct glycoproteins, HN and
F protein, are required for cell fusion [6]. HN is required for
the binding of HVJ to cell surface sialic acid receptors and
the subsequent degradation of the receptors by its sialidase
activity. Then, F associates with lipids, such as cholesterol,
in the cell membrane to induce cell fusion. When the viral rep-
lication is abolished by destroying viral genome with ultra-vio-
let rays (UV) irradiation, fusion activity is still maintained [5].
Our group discovered that inactivated HVJ particle (HVJ
envelope; HVJ-E) itself has tumor suppressive eﬀects by acti-
vating both innate immunity [7] and adaptive immunity [8].Abbreviations: HVJ, hemagglutinating virus of Japan; DCs, dendritic
cells; TLR, toll-like receptor; IFN, type I interferon; UV, ultra-violet
rays; MOI, multiplicity of infection; HAU, hemagglutinating unit;
PNGF, peptide-N-glycosidase F; EndoH, endoglycosidase H; Rev,
reconstituted virosome; Rel, reconstituted liposomes
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doi:10.1016/j.febslet.2008.03.011The highlighted ﬁnding of the immune reactions by HVJ-E is
the suppression of regulatory T cells by inducing IL-6 secretion
from dendritic cells (DCs) [8].
Regulatory T cells are known to negatively regulate T cell re-
sponses [9]. Therefore, regulatory T cell-mediated suppression
of anti-tumor immune responses must be overcome in order
for cancer immunotherapy to be successful. IL-6 has been re-
ported to control regulatory T cell proliferation. We have
shown that HVJ-E shows promise as a potential anti-cancer
agent through the induction of IL-6, but the speciﬁc compo-
nents of HVJ-E responsible for IL-6 induction have not been
examined until now.
Here, we analyzed the ability of various viral components to
induce IL-6 production in DCs and reached the conclusion
that F glycoprotein plays a major role in IL-6 production by
DCs in a fusion-independent manner.2. Materials and methods
2.1. Cell lines
The mouse colon cancer cell line CT26 and the human embryonal
kidney cell line HEK 293 were obtained from the Japanese Collection
of Research Bioresources. Murine bone marrow-derived DCs were
generated as previously described [7]. More than 90% of these DCs
were positive for CD11c.
2.2. HVJ
HVJ from chicken egg was prepared as described previously [6]. To
prepare cell-derived HVJ, HEK 293 cells were infected with wild type
HVJ [multiplicity of infection (MOI) = 0.4] for 1 h. After washing with
PBS, the cells were incubated for 48 h at 37 C. Then, viruses produced
from the infected cells were harvested and the virus supernatant was
passed through a 1.2 lm pore size ﬁlter and centrifuged (100000 · g
for 1 h at 4 C). The virus pellet was then re-suspended in PBS. The
virus was inactivated by UV irradiation (198 mJ/cm2) to form HVJ-E.
2.3. Trypsin treatment
The HVJ-E of 500 hemagglutinating unit (HAU) (1HAU @ 3 ·
106 particles) was incubated with 500 lg of trypsin in 1 ml OPTI-
MEM (GIBCO BRL, Rockville, MD, USA) at 37 C for 2 h. Then,
the HVJ-E was precipitated by centrifugation and suspended in buﬀer
B (150 mM NaCl, 10 mM Tris (pH 7.4), 2 mM CaCl2, and 2 mM
MgCl2) after being washed twice.
2.4. Glycosidase treatment
HVJ-E of 480 HAU was treated with 8 milliunits of peptide-N-gly-
cosidase F (PNGF) or 8 milliunits of endoglycosidase H (EndoH).
Each treatment was performed in 20 ll of buﬀer 1 (100 mM Tris–
HCl, pH 8.6) for PNGF digestion or 40 ll of buﬀer 2 (50 mM sodium
acetate, pH 5.5) for EndoH digestion at 37 C for 18 h. After digestion,
the virus was centrifuged (100000 · g for 1 h at 4 C) and the pellet was
re-suspended in buﬀer B.blished by Elsevier B.V. All rights reserved.
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Rev with F was prepared according to the Tomasi and Loyter meth-
od [10].
2.6. Preparation of reconstituted liposomes (Rel)
Lipids (cholesterol:phosphatidylcholine = 1:1 molar ratio; total
weight 8.142 mg) dissolved in chloroform were dehydrated in a rotary
evaporator and suspended in buﬀer B. The lipid suspension was agi-
tated on a vortex for 30 s and incubated at 37 C for 30 s. This step
was repeated eight times. Either F protein or HN protein was puriﬁed
by applying detergent-solubilized HVJ supernatant on an ion-exchange
column as described previously [11]. Each protein fraction containing
1% Triton X-100 (1.2 ml) was added to the liposome suspension, and
the suspension was mixed with 27.5 mg of SM-2 Bio-Beads to remove
Triton X-100 by incubation for 5 h at room temperature, followed by
40 h at 4 C.
2.7. Cytokine measurements
Each cytokine was measured as previously described [8]. To inhibit
HVJ-E-mediated IL-6 production in DCs, HVJ-E was pre-incubated
with anti-HN or anti-F rabbit serum at 37 C for 60 min according
to the previous method [12].
2.8. Statistical analysis
All experiments were done more than three times. Statistical analysis
was done with the unpaired t-test and P < 0.05 was considered to indi-
cate statistical signiﬁcance.Fig. 1. ELISA of IL-6 or IFN-b secreted into the medium of DCs after
stimulation with trypsin-treated or untreated HVJ-E. The abscissa
represents the dilution of HVJ-E. 3 · 108 particles of HVJ-E were used
at undiluted point ‘‘1’’.3. Results
3.1. A fusion event is not necessary for IL-6 production
First, we examined whether fusion between viral envelope
and cell membrane is necessary for the production of IL-6 in
mouse DCs. HVJ containing F1 (+ trypsin) fuses with the cell
membranes of mouse DCs, whereas HVJ containing F0 (
trypsin) fails to fuse. As shown in Fig. 1, IL-6 secretion into
the culture medium increased in a dose-dependent manner fol-
lowing treatment of DCs with HVJ containing either F1 or F0.
However, while the secretion of interferon (IFN)-b into the
culture medium was increased in the presence of HVJ contain-
ing F1, it was not in the presence of F0.
These results suggest that fusion of HVJ with the cell mem-
brane is not necessary for stimulation of IL-6 production.
3.2. Reconstituted particles with HVJ components
Next, we examined which surface components of HVJ stim-
ulate IL-6 production in DCs. First, Rev with F protein and
Rev with both HN and F protein were prepared. Rev with
equivalent amounts of HVJ surface proteins as HVJ-E were
used in the DC experiment. Rev with both HN and F increased
IL-6 production to the same extent as HVJ-E (Fig. 2). Further-
more, Rev with F alone produced a similar amount of IL-6
from DCs. Additionally, TNF-a was up-regulated by both
HVJ-E and Rev with F, whereas IL-1b was not produced by
either HVJ-E or Rev with F (Supplementary Fig. 1). IFN-a
and -b were produced by HVJ-E, not by Rev with F. On the
maturation of DCs, the expression of CD40, 80 and 86 was
not induced by Rev with F, although HVJ-E caused the mat-
uration of DCs (Supplementary Fig. 2).
Then, Rel with F and Rel with HN were prepared and used
to examine IL-6 production from DCs. As shown in Fig. 3, Rel
with F stimulated IL-6 production, although IL-6 production
by Rel with F was lower than HVJ-E containing same amount
of F. However, Rel with HN failed to stimulate IL-6 produc-
tion. When isolated F or HN protein was added to DCs, nei-ther protein stimulated IL-6 production as seen in Fig. 3.
However, IL-6 secretion was increased by the presence of F
protein in a dose-dependent manner. Similar levels of IL-6 pro-
duction were observed when DCs were treated with concentra-
tions of F protein greater than 20-fold that found within F-
containing liposomes. These results indicate that F protein,
and not HN protein, is important for IL-6 production in DCs.
To conﬁrm the results of reconstituted particles, we exam-
ined the eﬀect of anti-F antibody on the inhibition of IL-6 pro-
duction in DCs. By the pre-incubation of HVJ-E (3 · 109) with
20 ll of anti-F rabbit serum, the production of IL-6 in the cul-
ture medium of DCs was signiﬁcantly reduced compared with
that by either anti-HN rabbit serum or pre-immune rabbit ser-
um (Fig. 4). Twenty microliter of anti-F serum contained an
excess amount of anti-F antibody recognizing all the particles
of HVJ-E used in this experiment [12].
Therefore, we concluded that F protein, not HN protein,
elicited the IL-6 production in mouse DCs.
3.3. Requirement of F protein carbohydrate for IL-6 production
in DCs
F and HN are surface glycoproteins of HVJ [13]. Then, the
involvement of carbohydrate chains of those glycoproteins in
IL-6 production was investigated. HN is a high-mannose type
carbohydrate sensitive to endoglycosidase H (Endo H), while
F is a complex type carbohydrate chain resistant to Endo H
[14]. For complete removal of carbohydrate chains from F
glycoprotein, treatment with peptide-N-glycosidase F (PNGF)
is necessary. This was conﬁrmed in the present study by com-
paring total protein staining with carbohydrate chain-speciﬁc
staining of HVJ glycoproteins after treatment with either
Endo H or PNGF (Fig. 5A). HVJ-E treated with Endo H
stimulated IL-6 secretion from DCs to the same extent as in-
Fig. 2. ELISA of IL-6 secreted from DCs (105 cells) after stimulation with Rev. As a positive control, whole HVJ-E particles were used in both cases.
The abscissa represents the dilution of HVJ-E and Rev. 3 · 108 particles of HVJ-E were used at undiluted point ‘‘1’’. At the same strength of dilution,
HVJ-E and Rev contained similar amounts of envelope proteins determined by the density of F protein in protein staining.
Fig. 3. ELISA of IL-6 within the culture medium of DCs stimulated with Rel containing F or HN and puriﬁed F or HN protein. At the same
strength of dilution, the amount of F protein (either puriﬁed F or Rel containing F) was similar to that observed in HVJ-E in this experiment. The
abscissa represents the dilution of Rel. F or HN protein equal to each protein in 3 · 108 particles of HVJ-E was used at undiluted point ‘‘1’’. ‘‘·20’’
indicates that the amount of F protein exceeded that found in 3 · 108 particles of HVJ-E by 20-fold.
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lost the ability to stimulate IL-6 production in DCs. The
supernatant of HVJ-E treated with EndoH or PNGF was
heated to inactivate the glycosidase and added to DCs. Nostimulation of IL-6 was seen (data not shown). These results
suggest that F glycoprotein, rather than its polypeptide or
an isolated carbohydrate chain, is required for stimulation
of IL-6 production in DCs.
Fig. 4. IL-6 production in DCs by HVJ-E treated with anti-F or -HN
antibody. As a negative control, preimmune rabbit serum was used.
The abscissa represents the dilution of HVJ-E. 3 · 108 particles of
HVJ-E were used at undiluted point ‘‘1’’.
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We have previously reported that intratumor injection of
HVJ-E eﬀectively regresses CT26 tumors in mice by enhancingFig. 5. (A) Polypeptide staining with Coomassie (on the left) and carbohydra
electrophoresis of HVJ-E treated with Endo H or PNGF or in the absence o
each treatment are also presented (on the right). (B) ELISA of IL-6 in the med
The abscissa indicates which dilution of HVJ-E was used for the experimenT-cell immunity. In this model, inhibition of regulatory T cells
by IL-6 production was observed to play an important role in
activation of anti-tumor immunity and injection of IL-6 recep-
tor antibody greatly reduced the anti-tumor eﬀect of HVJ-E in
the CT26 tumor model [8]. Thus, we expected that Rev con-
taining F might be suﬃcient to inhibit CT26 growth in mice.
When serial injections of Rev containing F were administered
into a CT26 tumor mass, signiﬁcant regression of the tumor
mass was observed. No signiﬁcant diﬀerence in tumor regres-
sion was observed between Rev containing F and HVJ-E (Sup-
plementary Fig. 3).4. Discussion
In this manuscript, we identiﬁed F glycoprotein of the Sendai
virus as an IL-6 inducer in DCs. Fig. 3 conﬁrms that isolated F
protein was capable of inducing IL-6 secretion from DCs,
although with less eﬃciency than F-liposomes. It is possible
that isolated F might aggregate due to its hydrophobic regionste staining with Pro-Q Emerald 488 (in the center) were performed after
f glycosidase. The results of Western blotting of HVJ HN and F1 after
ium of DCs stimulated by glycosidase-treated HVJ-E or intact HVJ-E.
t. 3 · 108 particles of HVJ-E were used at undiluted point ‘‘1’’.
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form the correct three-dimensional structure as it exists on
the virus particle. When similar amount of F protein was used,
Rev with F induced IL-6 production as much as HVJ-E whole
particle, while Rel with F produced lower level of IL-6 in DCs.
Lipid components of Rel (phosphatidyl choline and choles-
terol) might be insuﬃcient for correct three-dimensional struc-
ture of F protein because the topology of F protein are
maintained by interaction with multiple lipids on the viral enve-
lope [16]. At this point, there remains a possibility that polypep-
tide or carbohydrate chains of F might be involved in IL-6
stimulation since F is a glycoprotein with N-linked complex
type carbohydrate chains [17]. The results of Fig. 5 suggest that
DCs recognize a glycoprotein form of F protein, rather than its
polypeptide or an isolated carbohydrate chain. The role of car-
bohydrate chains on viral surface proteins has not been fully
elucidated, although several possibilities have been suggested,
including intracellular traﬃcking of the proteins [18] and pro-
tein immunogenicity [19]. Our results indicate that carbohy-
drate on the F-glycoprotein might stimulate IL-6 production
through association with a DC surface molecule.
Next issue is the detection of a DC surface molecule to medi-
ate the signal by F glycoprotein. It is well known that LPS,
TNF and IL-1 stimulate IL-6 production via TLRs in various
cells such as macrophages, B-, T-lymphocytes, ﬁbroblasts and
keratinocytes [20]. It is reported that IL-6 production by HVJ
was not aﬀected in DCs of Myd88-deﬁcient mouse [2]. Since
TLR4-mediated signal transduction is independent upon
Myd88 [21], TLR4-deﬁcient DCs were prepared from bone
marrow of C3H/HeJ mouse. IL-6 production also occurred
in TLR4-negative DCs by either HVJ-E or Rev with F protein
as well as TLR4-positive DCs from C3H/HeN (data not
shown). Thus, IL-6 production by F glycoprotein is fully inde-
pendent upon TLRs.
We have shown that IL-6 plays a major role in HVJ-E-in-
duced anti-tumor immunity in a CT26 tumor model [8]. Given
that regulatory T cell-mediated suppression of anti-tumor im-
mune reactions needs to be overcome for cancer immunother-
apy to be successful, F glycoprotein of HVJ provides a
promising tool in cancer therapy. From the safety point of
view, Rev with F appears to be safer than HVJ-E whole parti-
cle in systemic injection because HN is capable of hemaggluti-
nating red blood cells, but F does not have such eﬀect.
However, the immune response against F protein should be
carefully examined in repeated injection.
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